🇺🇸 PTGX — Protagonist Therapeutics, Inc.

Salud Compra fuerte
← Volver

Precio actual

140,24 USD

Máx. histórico

158,62

78 días

Caída desde máximo

-11,59%

Rango 52 semanas

75,44 – 160,81

Variación hoy

+0,62%

Cierre anterior

139,37

Rango de hoy

139,91 – 144,27

Volumen hoy

673.087

Peor caída histórica

-85,79%

01/09/2021 → 13/06/2022

Recuperado en 1001 días

Volatilidad anualizada ⓘ

89,34%

Información
Nombre completo
Protagonist Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGM
Sector
Salud
Industria
Biotechnology
Empleados
141
PER ⓘ
136,16 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
178,57 USD (puede no estar actualizado)
Primera cotización
11/08/2016
Precio actualizado
hace 9 horas
Sobre la empresa

Protagonist Therapeutics, Inc. operates as a discovery and development company in the United States. It develops Icotyde, a first-in-class investigational targeted oral peptide for the treatment of adults and pediatric patients 12 years of age and older with moderate-to-severe plaque psoriasis; and Rusfertide, a first-in-class investigational injectable mimetic of the natural hormone hepcidin in Phase 3 development for the treatment of the rare blood disorder polycythemia vera. The company is also developing PN-881, a potential best-in-class oral peptide IL-17 antagonist, for the treatment of immune-mediated skin diseases in Phase 1 clinical trials; PN-477 and PN-458, which are development candidates for the treatment of obesity; PN-8047, an orally administered hepcidin functional mimetic small molecule; L-4R alpha antagonist for the treatment of atopic dermatitis and moderate-to-severe asthma; and amylinR-based oral and subcutaneous mono- and poly-agonists for the treatment of obesity. Protagonist Therapeutics, Inc. was incorporated in 2006 and is headquartered in Newark, California.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
13/07/2017 13,30 14,12 13,21 13,93 +3,88% 6,84% 75.100
12/07/2017 13,23 13,65 13,10 13,41 +1,82% 4,20% 40.100
11/07/2017 12,49 13,51 12,21 13,17 +6,38% 10,41% 55.000
10/07/2017 12,69 12,88 12,36 12,38 -2,44% 4,10% 43.400
07/07/2017 11,91 12,74 11,91 12,69 +5,75% 6,93% 136.400
06/07/2017 12,00 12,15 11,69 12,00 +0,93% 3,83% 78.600
05/07/2017 11,29 12,13 11,15 11,89 +4,30% 8,74% 93.300
03/07/2017 11,44 11,61 11,20 11,40 +0,80% 3,58% 24.000
30/06/2017 11,52 11,66 11,11 11,31 -1,99% 4,77% 45.500
29/06/2017 12,25 12,25 11,26 11,54 -3,83% 8,12% 106.300
28/06/2017 11,13 12,24 11,13 12,00 +7,91% 9,97% 142.000
27/06/2017 11,98 11,98 11,02 11,12 -7,33% 8,01% 70.100
26/06/2017 12,07 12,10 11,15 12,00 +0,00% 7,87% 117.600
23/06/2017 12,09 12,09 11,81 12,00 -0,66% 2,32% 268.000
22/06/2017 12,33 12,33 11,80 12,08 -0,25% 4,30% 83.200
21/06/2017 12,04 12,22 11,75 12,11 +3,42% 3,90% 101.700
20/06/2017 11,11 12,09 10,87 11,71 +5,12% 10,98% 59.200
19/06/2017 10,58 11,23 10,55 11,14 +5,59% 6,43% 53.800
16/06/2017 10,70 10,97 10,42 10,55 -2,68% 5,19% 72.400
15/06/2017 10,92 11,20 10,77 10,84 -1,99% 3,94% 115.100
14/06/2017 10,96 11,36 10,72 11,06 +0,91% 5,84% 142.000
13/06/2017 11,05 11,41 10,89 10,96 -1,35% 4,71% 226.400
12/06/2017 11,38 11,73 11,01 11,11 -2,37% 6,32% 132.800
09/06/2017 10,78 11,76 10,65 11,38 +5,57% 10,30% 143.900
08/06/2017 10,70 11,34 10,41 10,78 +1,41% 8,73% 217.100
07/06/2017 10,42 11,00 10,25 10,63 +1,14% 7,20% 110.400
06/06/2017 10,55 10,76 10,50 10,51 -0,85% 2,46% 116.700
05/06/2017 10,54 11,00 10,25 10,60 -0,75% 7,12% 105.900
02/06/2017 10,80 11,02 10,65 10,68 -1,93% 3,47% 231.600
01/06/2017 11,41 11,74 10,50 10,89 -2,51% 10,84% 243.600